CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice-Reference-Cited by-同舟云学术

CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice

Published:2020-07 Issue: Volume:141 Page:104954
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Yamagata Tetsushi,Raveau Matthieu,Kobayashi Kenta,Miyamoto Hiroyuki,Tatsukawa Tetsuya,Ogiwara Ikuo,Itohara Shigeyoshi,Hensch Takao K.,Yamakawa Kazuhiro

Funder

RIKEN Center for Brain Science

RIKEN-CBS

Takeda Pharmaceutical Company Ltd.

AMED

Publisher

Elsevier BV

Subject

Neurology

Reference49 articles.

1. A monomeric red fluorescent protein;Campbell;Proc. Natl. Acad. Sci. U. S. A.,2002

2. Efficacy of stiripentol in hyperthermia-induced seizures in a mouse model of Dravet syndrome;Cao;Epilepsia,2012

3. Nonfunctional NaV1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects;Cestèle;Proc. Natl. Acad. Sci. U. S. A.,2013

4. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems;Chan;Nat. Neurosci.,2017

5. Highly efficient Cas9-mediated transcriptional programming;Chavez;Nat. Methods,2015

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic therapies and potential therapeutic applications of CRISPR activators in the eye;Progress in Retinal and Eye Research;2024-09

2. Application of novel CRISPR tools in brain therapy;Life Sciences;2024-09

3. CRISPR activation screens: navigating technologies and applications;Trends in Biotechnology;2024-08

4. Accelerating therapeutic development and clinical trial readiness for STXBP1 and SYNGAP1 disorders;Current Problems in Pediatric and Adolescent Health Care;2024-08

5. Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications;Advanced Drug Delivery Reviews;2024-08